Research Site 230 — Missouri City, Texas

Research Site 230 is a clinical research site located in Missouri City, Texas, United States 77459.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site 230 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hypertriglyceridemia.

Sponsors: Arrowhead Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Missouri City

Browse all research sites in Texas · View every site in Missouri City

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site 230?

Research Site 230 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site 230 conducted?

Research Site 230 has 1 clinical trials on record, with 1 currently active. Their work covers Hypertriglyceridemia.

Is Research Site 230 accredited by Crixeo Clinical Trials?

Research Site 230 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site 230?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.